Haemodialysis-associated amyloidosis

	Amyloidosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification • Primary amyloidosis • Secondary amyloidosis • Familial amyloidosis • Wild-type (senile) amyloidosis • Cardiac amyloidosis • Beta-2 microglobulin related amyloidosis • Gelsolin related amyloidosis • Lysozyme amyloid related amyloidosis • Leucocyte cell-derived chemotaxin 2 related amyloidosis • Fibrinogen A alpha-chain associated amyloidosis
Pathophysiology
Causes
Differentiating Amyloidosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Haemodialysis-associated amyloidosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Haemodialysis-associated amyloidosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Haemodialysis-associated amyloidosis
CDC on Haemodialysis-associated amyloidosis
Haemodialysis-associated amyloidosis in the news
Blogs on Haemodialysis-associated amyloidosis
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Haemodialysis-associated amyloidosis

	WikiDoc Resources for Haemodialysis-associated amyloidosis
Articles
Most recent articles on Haemodialysis-associated amyloidosis Most cited articles on Haemodialysis-associated amyloidosis Review articles on Haemodialysis-associated amyloidosis Articles on Haemodialysis-associated amyloidosis in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Haemodialysis-associated amyloidosis Images of Haemodialysis-associated amyloidosis Photos of Haemodialysis-associated amyloidosis Podcasts & MP3s on Haemodialysis-associated amyloidosis Videos on Haemodialysis-associated amyloidosis
Evidence Based Medicine
Cochrane Collaboration on Haemodialysis-associated amyloidosis Bandolier on Haemodialysis-associated amyloidosis TRIP on Haemodialysis-associated amyloidosis
Clinical Trials
Ongoing Trials on Haemodialysis-associated amyloidosis at Clinical Trials.gov Trial results on Haemodialysis-associated amyloidosis Clinical Trials on Haemodialysis-associated amyloidosis at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Haemodialysis-associated amyloidosis NICE Guidance on Haemodialysis-associated amyloidosis NHS PRODIGY Guidance FDA on Haemodialysis-associated amyloidosis CDC on Haemodialysis-associated amyloidosis
Books
Books on Haemodialysis-associated amyloidosis
News
Haemodialysis-associated amyloidosis in the news Be alerted to news on Haemodialysis-associated amyloidosis News trends on Haemodialysis-associated amyloidosis
Commentary
Blogs on Haemodialysis-associated amyloidosis
Definitions
Definitions of Haemodialysis-associated amyloidosis
Patient Resources / Community
Patient resources on Haemodialysis-associated amyloidosis Discussion groups on Haemodialysis-associated amyloidosis Patient Handouts on Haemodialysis-associated amyloidosis Directions to Hospitals Treating Haemodialysis-associated amyloidosis Risk calculators and risk factors for Haemodialysis-associated amyloidosis
Healthcare Provider Resources
Symptoms of Haemodialysis-associated amyloidosis Causes & Risk Factors for Haemodialysis-associated amyloidosis Diagnostic studies for Haemodialysis-associated amyloidosis Treatment of Haemodialysis-associated amyloidosis
Continuing Medical Education (CME)
CME Programs on Haemodialysis-associated amyloidosis
International
Haemodialysis-associated amyloidosis en Espanol Haemodialysis-associated amyloidosis en Francais
Business
Haemodialysis-associated amyloidosis in the Marketplace Patents on Haemodialysis-associated amyloidosis
Experimental / Informatics
List of terms related to Haemodialysis-associated amyloidosis

	Haemodialysis-associated amyloidosis;
ICD-10	E85.3
ICD-9	277.3
eMedicine	med/3384

Haemodialysis-associated amyloidosis is a form of amyloidosis associated with chronic renal failure.^[1]

Presentation

Long term haemodialysis results in a gradual accumulation of β₂ microglobulin, a serum protein, in the blood. It accumulates because it is unable to cross the dialysis filter.

Prevention

Low copper dialysis is theorized to prevent or delay onset.^[2]

References

↑ Miyata T, Oda O, Inagi R; et al. (1993). "beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis". J. Clin. Invest. 92 (3): 1243–52. doi:10.1172/JCI116696. PMC 288264. PMID 8376584. Unknown parameter |month= ignored (help)
↑ "BU". Text " Amyloid Treatment & Research Program " ignored (help); Text " Doctors " ignored (help); Text " Aß2M Amyloidosis " ignored (help); Text " Clinical Features " ignored (help)

Template:Nephrology

Template:WikiDoc Sources

[pmid8376584-1] Miyata T, Oda O, Inagi R; et al. (1993). "beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis". J. Clin. Invest. 92 (3): 1243–52. doi:10.1172/JCI116696. PMC 288264. PMID 8376584. Unknown parameter |month= ignored (help)

[urlBU_|_Amyloid_Treatment_&_Research_Program_|_Doctors_|_Clinical_Features_|_Aß2M_Amyloidosis-2] "BU". Text " Amyloid Treatment & Research Program " ignored (help); Text " Doctors " ignored (help); Text " Aß2M Amyloidosis " ignored (help); Text " Clinical Features " ignored (help)

[1]

[2]

Haemodialysis-associated amyloidosis

Presentation

Prevention

References

Navigation menu

Search